BeiGene Announces Global Licensing Agreement for MAT2A Inhibitor

Our ambition is to be a leading corporate citizen, acting with courage, creativity, and discipline to provide equitable benefit to our patients, business, and society. Our commitment to Responsible Business & Sustainability centers on four focus areas:

• Advancing Global Health – We will develop impactful medicines that will be accessible to far more patients around the world
• Empowering Our Colleagues – We will create inclusive and equitable opportunities for our people to thrive and make a lasting positive impact in the world
• Innovating Sustainably – We will take action to mitigate our impact on the environment and ensure business continuity
• Operating Responsibly – We will operate with integrity, transparency, and discipline to ensure we are meeting the diverse expectations of our stakeholders

For more information about our strategy, please visit the Responsibility section of our website or access the following resources: